Inventor · disambiguated record
Mohit Trikha
Also filed as: TRIKHA MOHIT
15 granted patents·11 pending applications·663 citations·filing 1996–2022
95Inventor score
Files withCENTOCOR INC7GILES-KOMAR JILL5CELGENE INT II SARL3UNIV WAYNE STATE2CELGENE TRI A HOLDINGS LTD1
Top patents by PatentIndex Score
26 records- 0198US7955597B2Anti-IL-6 antibodies, compositions, methods and usesCENTOCOR INC·Filed 2009·Granted Jun 7, 2011·61 cites·5 claims
- 0298US7612182B2Anti-IL-6 antibodies, compositions, methods and usesCENTOCOR INC·Filed 2007·Granted Nov 3, 2009·76 cites·15 claims
- 0398US7291721B2Anti-IL-6 antibodies, compositions, methods and usesCENTOCOR INC·Filed 2002·Granted Nov 6, 2007·162 cites·9 claims
- 0497US7833786B2Anti-IL-6 antibodies, compositions, methods and usesCENTOCOR INC·Filed 2007·Granted Nov 16, 2010·44 cites·4 claims
- 0597US7550142B2Anti-integrin antibodies, compositions, methods and usesCENTOCOR INC·Filed 2006·Granted Jun 23, 2009·71 cites·14 claims
- 0697US7163681B2Anti-integrin antibodies, compositions, methods and usesCENTOCOR INC·Filed 2003·Granted Jan 16, 2007·132 cites·20 claims
- 0796US8071729B2Anti-integrin antibodies, compositions, methods and usesGILES-KOMAR JILL·Filed 2007·Granted Dec 6, 2011·51 cites·21 claims
- 0885US8603483B2Anti-integrin immunoconjugates, methods and usesCHEN QIMING·Filed 2005·Granted Dec 10, 2013·8 cites·15 claims
- 0983US8071333B2Anti-integrin antibodies, compositions, methods and usesGILES-KOMAR JILL·Filed 2009·Granted Dec 6, 2011·4 cites·3 claims
- 1078US5731288ACompositions containing contortrostatin and methods for the use thereofUNIV SOUTHERN CALIFORNIA·Filed 1996·Granted Mar 24, 1998·34 cites·8 claims
- 1175US8536113B2EGFR binding peptides and uses thereofTRIKHA MOHIT·Filed 2007·Granted Sep 17, 2013·4 cites·12 claims
- 1272US7288390B2Anti-dual integrin antibodies, compositions, methods and usesCENTOCOR INC·Filed 2001·Granted Oct 30, 2007·5 cites·14 claims
- 1369US2023181534A1Use of a proteasome inhibitor for the treatment of central nervous system (cns) cancersCELGENE INT II SARL·Filed 2022·Application pending·0 cites
- 1465US2014141013A1Anti-il-6 antibodies, compositions, methods and usesJANSSEN BIOTECH INC·Filed 2014·Application pending·0 cites
- 1562US6046316ANucleic acid encoding truncated integrinsUNIV WAYNE STATE·Filed 1997·Granted Apr 4, 2000·10 cites·1 claims
- 1660US11980606B2Use of marizomib for the treatment of central nervous system (CNS) cancersCELGENE INT II SARL·Filed 2020·Granted May 14, 2024·0 cites·8 claims
- 1760US2012096569A1Anti-il-6 antibodies,compositions, methods and usesGILES-KOMAR JILL·Filed 2011·Application pending·0 cites
- 1858US2011218329A1Anti-il-6 antibodies, compositions, methods and usesGILES-KOMAR JILL·Filed 2011·Application pending·0 cites
- 1956US2012058128A1Anti- integrin antibodies, compositions, methods and usesGILES-KOMAR JILL·Filed 2011·Application pending·0 cites
- 2051US2014093523A1Anti-Integrin Immunoconjugates, Methods and UsesIMMUNOGEN INC·Filed 2013·Application pending·0 cites
- 2149US2020085789A1Use of a proteasome inhibitor for the treatment of central nervous system (cns) cancersCELGENE INT II SARL·Filed 2018·Application pending·0 cites
- 2242US2005100550A1Anti-angiogenic uses of IL-6 antagonistsFiled 2003·Application pending·0 cites
- 2338US6218514B1Antibodies specific for soluble truncated integrinsUNIV WAYNE STATE·Filed 1999·Granted Apr 17, 2001·1 cites·6 claims
- 2438US2017348284A1Use of marizomib for the treatment of central nervous system (cns) cancersCELGENE TRI A HOLDINGS LTD·Filed 2017·Application pending·0 cites
- 2534US2005084492A1Assay method to monitor the response of anti-cytokine therapyFiled 2004·Application pending·0 cites
- 2632US2004161426A1Use of IL-6 antagonists in combination with steroids to enhance apoptosisFiled 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →